PROSTATE CANCER RECURRENT
Clinical trials for PROSTATE CANCER RECURRENT explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CANCER RECURRENT trials appear
Sign up with your email to follow new studies for PROSTATE CANCER RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise in slowing advanced prostate cancer
Disease control CompletedThis study tested whether adding the experimental drug lorigerlimab to standard chemotherapy (docetaxel) can delay cancer growth in men with a type of advanced prostate cancer that no longer responds to hormone therapy. About 150 participants received either the combination or ch…
Matched conditions: PROSTATE CANCER RECURRENT
Phase: PHASE2 • Sponsor: MacroGenics • Aim: Disease control
Last updated May 26, 2026 03:20 UTC
-
New imaging methods may improve detection of returning prostate cancer
Diagnosis CompletedThis study tested whether two advanced imaging techniques, Histoscanning and multiparametric MRI, can more accurately detect and locate prostate cancer that returns after radiation therapy. Thirty men with signs of recurrence underwent both scans, followed by targeted and random …
Matched conditions: PROSTATE CANCER RECURRENT
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated May 26, 2026 03:13 UTC